Denis Chem Lab Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Denis Chem Lab Ltd is ₹ 77.43 as of 07 May 15:30 . The p/e ratio of Denis Chem Lab Ltd changed from 15.9 to 18.8 over 5 quarters. This represents a CAGR of 14.34% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Denis Chem Lab Ltd changed from ₹ 128.57 crore to ₹ 209.33 crore over 5 quarters. This represents a CAGR of 47.69% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Denis Chem Lab Ltd for the Dec '25 is ₹ 45.96 crore as compare to the Sep '25 revenue of ₹ 46.82 crore. This represent the decline of -1.84% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The ebitda of Denis Chem Lab Ltd for the Dec '25 is ₹ 6.46 crore as compare to the Sep '25 ebitda of ₹ 4.91 crore. This represent the growth of 31.57% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The net profit of Denis Chem Lab Ltd changed from ₹ 1.76 crore to ₹ 3.32 crore over 7 quarters. This represents a CAGR of 43.71% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The dividend payout of Denis Chem Lab Ltd changed from 25.77 % to 31.09 % over 5 quarters. This represents a CAGR of 16.20% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Denis Chem Lab Ltd

Denis Chem Lab Limited was incorporated in 1980 and was converted into a Public Limited Company in 1982.
The Company was registered with Directorate General of Technical Development (DGTD) for manufacturing 4 million bottles of I.V. Fluids and 75 MT of Bulk Drugs per annum and started commercial production for sterile Intravenous (IV) Injectibles in 1984 and also came up with a rights issue during the year In 1995, it ventured into manufacturing of IV Fluids in PP bottles using BFS technology. The Company is engaged in manufacturing of Pharmaceuticals Transfusion Solution in Bottles.
The Company products are manufactured in ultra modern plant using automatic equipments and facilities, which are conforming to GMP specifications as per WHO norms. These products are filled in glass bottles in volume of 100 ml, 250 ml, 500 ml and 1000 ml.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Denis Chem Lab Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Denis Chem Lab Ltd or Procter & Gamble Health Ltd?

Market cap of Denis Chem Lab Ltd is 107 Cr while Market cap of Procter & Gamble Health Ltd is 8,821 Cr

What are the key factors driving the stock performance of Denis Chem Lab Ltd and Procter & Gamble Health Ltd?

The stock performance of Denis Chem Lab Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Denis Chem Lab Ltd and Procter & Gamble Health Ltd?

As of May 7, 2026, the Denis Chem Lab Ltd stock price is INR ₹77.43. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5314.25.

How do dividend payouts of Denis Chem Lab Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Denis Chem Lab Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.